D
ynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) of the breast has been the mainstay of breast MRI with an excellent sensitivity. 1Y5 However, it is limited by a low specificity. 6, 7 Dynamic contrast-enhanced MRI of the breast provides morphologic information and limited functional information regarding angiogenesis and tumor vascularity. Available data suggest that the use of other functional MRI parameters such as diffusion-weighted imaging (DWI) with quantitative apparent diffusion coefficient (ADC) mapping and proton magnetic resonance (MR) spectroscopic imaging ( 1 H-MRSI) may provide additional specificity. 8Y15 Diffusion-weighted imaging reflects the diffusivity of water molecules in tissue. Typically, the movement of water is restricted in malignant cells. 16, 17 Proton MR spectroscopic imaging reflects tumor metabolism. Choline (Cho), a marker of cell turnover, is increased in breast cancer. 12,18Y20 To date, research groups have investigated multiparametric (MP) MRI of the breast using combinations of DCE-MRI with one additional functional MRI parameter, for example, DWI or 1 H-MRSI. The results obtained with MP MRI of the breast using 2 parameters were promising. 9Y13,21,22 However, to our knowledge, the diagnostic accuracy of a combination of 3 parameters (DCE MRI, DWI, and 3-dimensional [3D] 1 H-MRSI) has not been performed. The number of parameters necessary to significantly improve the accuracy of breast cancer diagnosis is unknown. In this study, we aimed to assess the diagnostic accuracy of 3 parameters (DCE MRI, DWI, and 3D 1 H-MRSI) in comparison with dual-parameter (DCE MRI and DWI) and single-parameter DCE MRI.
MATERIALS AND METHODS

Patients
This prospective; single-institution study was approved by the institutional review board of the Medical University of Vienna. Written informed consent was obtained from all patients before their MRI examination. From September 2008 to December 2012, a total of 133 consecutive female patients were enrolled in this study. They underwent MP MRI of the breast with DCE-MRI, DWI, and 3D 1 H-MRSI. The inclusion criteria were as follows: age of 18 years or older and an abnormality at mammography or breast ultrasound (asymmetric density, architectural distortion, suspicious microcalcifications, or breast mass; Breast Imaging Reporting and Data System (BI-RADS) category 0 or 4Y5). The exclusion criteria were pregnancy, lactation, prior treatment (eg, breast biopsy before MRI, neoadjuvant chemotherapy), and contraindications to MRI or contrast agents. 1 In addition to the previously mentioned criteria, 12 patients were excluded because of the technical failure of 3D 1 H-MRSI (frequency shift 91 ppm resulting in insufficient water and/or fat suppression) and 8 patients were excluded because of insufficient data quality because of motion artifacts, resulting in a total of 113 (mean age, 52 years; range, 22Y86 years) patients to be included in the study. Regardless of the results of MP MRI, histopathological verification of the lesion in question was performed. The initial BI-RADS category
MR Imaging
All patients underwent MP MRI of the breast. All MR examinations were performed in the prone position using a 3-T MR scanner (Tim Trio; Siemens, Erlangen, Germany) and a dedicated 4-channel breast coil (InVivo, Orlando, FL). In premenopausal women, MRI was performed in the second week of the menstrual cycle. 1 The MRI sequence protocol was acquired in the following order: a) T2-weighted turbo spin echo sequence with fat suppression ( All patients were injected with a single dose of the contrast agent. Gadoterate meglumine (Dotarem; Guerbet, Roissy, France) was injected intravenously as a bolus (0.1 mmol/kg of body weight) at 4 mL/s, followed by a 20-mL saline flush using a power injector (Spectris Solaris EP; Medrad, Pittsburgh, PA). Application of the contrast agent was started at 75 seconds after starting the first coronal T1-weighted volume interpolated breathhold examination. The total examination time for the MP MRI protocol was approximately 34 minutes.
Data Analysis
Multiparametric MRI data were prospectively evaluated by 2 experienced breast radiologists (K.P., 7 years of experience in breast MRI; T.H., 16 years of experience in breast MRI) in consensus as previous studies have shown very good intraobserver and interobserver agreement by using the following evaluation of each MRI parameter. 8, 14 The readers were aware that the patients had a breast lesion, but they were not provided with the previous mammographic and sonographic imaging data or histopathological results.
MRI Parameters
DCE-MRI of the Breast
To distinguish between benign and malignant contrastenhancing lesions descriptors according to the American College of Radiology, BI-RADS lexicon was used. 24, 25 Lesions were classified as masses or nonYmass like enhancing lesions (NMLEs). According to the American College of Radiology MRI BI-RADS lexicon, the following descriptors were assessed for masses: shape (round, oval, lobulated, 26 For NMLE, the distribution (focal, regional, mutiple regions; segmental, ductal, linear, and diffuse), the pattern of enhancement (homogenous, heterogeneous, clumped, and stippled), and the symmetry were assessed.
Lesion enhancement kinetics were used to assess functional information. Regions of interest (ROIs) were manually drawn in the most enhancing part of a lesion, and intensity courses were plotted against time. For NMLE, the enhancements kinetics were not taken into account. The probability of malignancy was determined by assigning a final BI-RADS category. 6, 7, 24 In addition, the lesion size measuring the largest diameter in 1 plane was assessed.
Diffusion-Weighted Imaging
When assessing water diffusivity, highYb value (ie, 850 s/mm 2 ) images were visually evaluated for hyperintense regions that corresponded to enhancing lesions on DCE MRI. Three-dimensional ROIs were drawn manually on ADC maps in all lesions. Partial volume effects due to normal parenchyma at the border of the lesion and areas of necrotic tissue identified in the morphological and contrast-enhanced images were avoided. The ROIs were defined as slightly smaller than the actual lesions to avoid partial-volume effects.
Bogner et al 8 evaluated the diagnostic quality of DWI regarding apparent ADC accuracy. On the basis of receiver operating characteristic (ROC) curves, the optimal ADC threshold of 1.25 Â 10 j3 mm 2 /s for the differentiation between benign and malignant breast lesions was determined. This ADC threshold was applied in the current study. Lesions were classified as benign if ADC values were equal to or greater than 1. 
3D 1 H-MRSI
An experienced spectroscopist (S.G., more than 10 years of experience) evaluated the 3D 1 H-MRSI data. For the assessment of metabolic information, all 3D 1 H-MRSI voxels in the lesion volume as detected with DCE MRI were evaluated for elevated levels of Cho. The voxel with the maximum Cho signal-to-noise ratio (SNR) was determined. Gruber et al 12 evaluated the diagnostic accuracy of 3D 1 H-MRSI for the differentiation of benign and malignant breast lesions, on the basis of Cho SNR threshold levels, defining a threshold of 2.6. Choline SNR measurements are a commonly accepted approach in MR spectroscopy of the breast. 20 This Cho SNR threshold level was applied in the current study. A lesion was classified as malignant if SNR was equal to or greater than 2.6 and benign if SNR was lower than 2.6.
MP MRI With 2 Parameters
Dynamic Contrast-Enhanced MRI and DWI 
DWI and 3D 1 H-MRSI
In the current study, interpretation of DWI and 3D 1 H-MRSI data was always performed after identification of lesions on DCE MR images. Therefore, these 2 parameters were not assessed individually or in combination without the information provided by DCE MRI.
MP MRI With 3 Parameters
For the assessment of MP MRI with all 3 parameters (DCE MRI, DWI, and 3D 1 H-MRSI), the following reading scheme was used: If the results of DCE MRI, DWI, and 1 H-MRSI of the breast were positive, MP MRI was considered positive for malignancy (Fig. 1) .
If the results of DCE MRI, DWI, and 1 H-MRSI of the breast were negative, MP MRI was considered negative for malignancy.
If 2 of 3 parameters were positive, MP MRI was considered positive for malignancy (Figs. 2, 3) . If 2 of the 3 parameters were negative, MP MRI was considered negative for malignancy.
Histopathology
The final diagnosis was established through histopathology. All cases were read by 1 pathologist (Z.B-H, 6 years of experience in breast pathology). FIGURE 1. Invasive ductal carcinoma G3 in a 67-year-old woman retroareolar in the left breast. A to D, The indistinct irregular mass lesion (large arrow) demonstrates heterogeneous initial strong enhancement followed by a wash-out and is classified as BI-RADS 5 (suspicious finding) through DCE MRI of the breast. Note the clumped NMLE in the anterior aspect of the lesions representing an extensive intraductal component (small arrow) (E). The mass demonstrates low ADC values (0.988 Â 10 j3 mm 2 /s). F, In 3D 1 H-MRSI, the lesion presents with a Cho peak at 3.23 ppm (SNR, 7.45). Multiparametric MRI with 3 parameters accurately classifies the tumor as malignant.
All patients underwent image-guided needle biopsy, 27 surgical biopsy, mastectomy, or lumpectomy. In case of a benign histopathological diagnosis at image-guided needle biopsy, the final diagnosis was benign (n = 31). In case of discordant findings between histopathological diagnosis and imaging findings, the final diagnosis was established with open surgery (n = 4). In case of a high-risk lesion, which has an uncertain potential for malignancy, the final diagnosis was established with open surgery (n = 4). 27, 28 Statistical Methods All calculations were performed on a per-lesion basis. To calculate the sensitivity and specificity of DCE MRI of the breast, the assigned BI-RADS classifications for MRI data were dichotomized. Magnetic resonance imaging BI-RADS 1, 2, and 3 were considered as benign. Magnetic resonance imaging BI-RADS 4 and 5 were considered as malignant. Sensitivity, specificity, accuracy, negative predictive value (NPV), positive predictive value (PPV), and their 95% confidence intervals for DCE MRI of the breast and MP MRI with 2 and 3 parameters were calculated.
Histopathology was used as the criterion standard. Significant differences in sensitivity, specificity, NPV, PPV, and diagnostic accuracy were assessed through logistic regression for multiple measures (generalized estimating equations). Receiver operating characteristic curves were plotted, and the area under the curve (AUC) was determined. Statistical differences between the AUCs were assessed using the method proposed by DeLong et al. 29 A P value of less than or equal to 0.05 was considered a significant result.
RESULTS
There were 113 lesions with a lesion size ranging from 5 to 98 mm (mean, 29 mm). Histopathologic diagnosis revealed 74 lesions to be malignant and 39 to be benign ( Sensitivities, specificities, PPV, NPV, diagnostic accuracies, and the AUCs for DCE MRI and MP MRI with 2 or 3 MRI parameters are summarized in Table 2 .
Diagnostic Accuracy: ROC Analysis
Diagnostic accuracy was significantly higher with MP MRI using 3 parameters, that is, DCE MRI, DWI, and 3D 1 H-MRSI, with an AUC of 0.936 compared with DCE MRI alone with an AUC of 0.814 (P G 0.001) (Fig. 4 ).
Multiparametric MRI with 2 parameters, that is, DCE MRI and DWI or 3D 1 H-MRSI, did not improve diagnostic accuracy (AUC, 0.808) compared with DCE MRI alone (P = 0.323).
Diagnostic accuracy of MP MRI with 3 parameters was significantly higher compared with MP MRI with 2 parameters (P G 0.001).
Sensitivity, Specificity, NPV, and PPV Multiparametric MRI with 3 parameters, that is, DCE MRI, DWI, and 3D 1 H-MRSI, yielded the highest sensitivity (100%), which was maximized compared with DCE MRI with 98.6%. Multiparametric MRI with 3 parameters significantly increased specificity to 87.2% compared with DCE-MRI with 64.1% (P G 0.001). Multiparametric MRI with 2 parameters also maximized sensitivity to 100% but showed a decrease in specificity of 61.5%.
Positive predictive values of DCE MRI alone and MP MRI with 2 or 3 parameters for breast cancer diagnosis are summarized in Figure 5 . The PPV was significantly higher with MP MRI with 3 parameters at 93.7% compared with DCE MRI alone at 83.9% (P G 0.001). Multiparametric MRI with 2 parameters demonstrated lower PPVs of 83.1% compared with DCE MRI alone.
The NPV of MP MRI with either 2 or 3 parameters was increased to 100% compared with DCE MRI at 96.2%.
Multiparametric MRI with all 3 parameters allowed the elimination of the false-negative finding and a significant reduction in false-positive findings from 14 with DCE MRI and 15 with MP MRI with 2 parameters to 5 with 3 parameters (P = 0.002). Detailed histopathological results for all false-positive and false-negative lesions for DCE MRI and MP MRI are listed in Table 3 .
DISCUSSION
The results of our study show that the highest diagnostic accuracy for breast cancer diagnosis is achieved with MP MRI using 3 parameters, that is, DCE MRI, DWI, and 3D As demonstrated in our study, each MRI parameter has an incremental value, 8, 12, 23, 30 but only MP MRI with 3 parameters allows an increase in both sensitivity and particularly specificity, resulting in a significantly improved diagnostic accuracy. With MP MRI using parameters, there were no false negatives and there was a significant reduction in false-positive lesions compared with DCE MRI and MP MRI with 2 parameters. In addition, MP MRI with 3 parameters has the potential to eliminate almost two thirds of unnecessary breast biopsies recommended by DCE MRI alone. The results are in agreement with †Significantly different from MP MRI with 2 MR imaging parameters (P G 0.001). 3D 1 H-MRSI indicates 3-dimensional proton spectroscopic imaging; AUC, area under the curve; DCE MRI, dynamic contrast-enhanced magnetic resonance imaging; DWI, diffusion-weighted imaging; MP, multiparametric; MRI, magnetic resonance imaging; NPV, negative predictive value; PPV, positive predictive value. studies that have proven the additional value of MP MRI with more than 2 parameters in other neoplastic diseases such as brain and prostate cancer. 31Y37 It is evident that MP MRI leads to an increased scan time; however, the increase in diagnostic accuracy resulting in a reduction of unnecessary breast biopsies is beneficial for the patient and might even be cost-effective, although no formal cost-effectiveness analysis was performed.
Even with the use of MP MRI, there were some false-positive lesions. These comprised of 3 high-risk lesions at biopsy, which remained lesions with atypia at surgery. 38, 39 Studies have demonstrated that high-risk lesions such as atypical ductal hyperplasia are genetically advanced nonYobligatory precursors of invasive breast cancer. 40 The fact that these lesions remained false positive with MP MRI with all 3 parameters possibly reflects malignant potential. Another false positive was a very metabolically active juvenile fibroadenoma with a high cellularity. 41, 42 The other remaining false-positive lesion was a clinically asymptomatic chronic abscess, which demonstrated suspicious morphologic and kinetic features and decreased ADC levels, 43 21, 45 and Ei Khouli et al, 9 who used a logistic regression model, reported similar results for MP MRI with DCE MRI and DWI. In all these studies, the improvement of specificity led to a trade-off in sensitivity. In contrast, the combination approach in this study led to an increase in sensitivity to 100% but no increase in specificity.
Several H-MRSI has a higher sensitivity of 97%. We applied the same 3D 1 H-MRSI technique, and our results are concordant with these findings. It has to be kept in mind that MR spectroscopy even if performed as a 3D technique is limited to a certain region of one breast. As a consequence, it can only be considered as an additional tool for the characterization of lesions in a prior known location. This limits its application for the characterization of incidental small and nonYmasslike enhancements.
In the current study, interpretation of DWI and 3D 1 H-MRSI data was always performed after identification of lesions on DCE MR images. There have been approaches described for lesion identification in DWI on high b-value images, 22, 46 but no data exist for the application of 3D 1 H-MRSI in breast imaging without lesion identification on DCE MR images. Because lesion identification on DCE MR images is the most commonly used approach, we chose to use this in the current study; therefore, DWI and 3D 1 H-MRSI were not assessed individually or in combination.
The data suggest that MP MRI with 2 parameters is not as beneficial as MP MRI with 3 parameters with respect to diagnostic accuracy.
However, there are other approaches for the combination of quantitative multiparametric data than the empirical approach chosen in this study. Methods such as classification trees, logistic regression, or artificial neural networks have been described. These methods are able to combine raw quantitative data and assign a probability of malignancy. Although desirable, these approaches are limited FIGURE 4. The ROC curves illustrate the higher diagnostic value (that is, higher sensitivity, specificity, and larger AUC) that is reached for MP MRI with 3 parameters compared with DCE MRI of the breast and MP MRI with 2 parameters. To date, because of these limitations, only little data on multivariate data combinations and no data using MP MRI has been published in breast MRI. 47, 48 The approach used in the current study was defined before commencement of the study, was readily applicable in clinical practice, and achieved high diagnostic accuracies.
There was a relatively small number of pure ductal carcinoma in situ and invasive lobular cancers as compared with the number of invasive ductal cancers. Consequently, there was also a relatively small number of NMLEs, which often represent ductal carcinoma in situ and invasive lobular carcinoma. This limits the specific insights into the performance of MP MRI in these subgroups. However, in a prospective study with consecutive patients, the collective distribution of malignant lesion subtypes is as expected and underlines the representativeness of our patient sample. In addition, the readers in this study were experienced breast radiologists with extensive training in the interpretation of breast MR images; therefore, the results might not be applicable to every radiologist. However, it can be expected that dedicated training and the addition of computer-aided detection systems that implement all MR imaging parameters will be helpful for radiologists in everyday practice. All MR examinations were performed at 3 T instead of 1.5 T, which is the most commonly used field strength in breast MRI. This should not be seen as a limitation because 3 T offers advantages such as an improved temporal and spatial resolution. 6, 8, 12, 14, 23 
CONCLUSIONS
In conclusion, MP MRI with 3 parameters (DCE-MRI, DWI, and 3D-1 H-MRSI) has a greater diagnostic accuracy for breast cancer diagnosis than DCE-MRI alone or MP MRI with only 2 MRI parameters.
